Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916183 · ClinicalTrials.gov registry record · NA
Dehydration Cognition
A NA study of Dehydration, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05916183: Completed NA study of Dehydration, sponsored by State University of New York at Buffalo.
NCT05916183 is a NA study of Dehydration that has completed, run by State University of New York at Buffalo. The registered enrollment target is 15 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05916183, a NA study of Dehydration, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators want to understand the impact of the body losing and gaining water on brain function. Participants will restrict fluids consumed and exercise to lose 5% of body mass. Participants will then be provided fluid equal to the volume lost to consume over 2 hours (recovery). A series of brain function tests will be performed at baseline, following weight loss, and following recovery.
Primary Outcome
Accuracy score of a multitasking test (0-100%) with greater scores indicating a better outcome
Conditions Studied
Interventions
- BEHAVIORAL Fluid loss and consumption
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2023-12-22 |
| Phase | NA |
What the finished NCT05916183 record still lists
NCT05916183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 1 intervention - of which Fluid loss and consumption is the first listed.
NCT05916183 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05916183 about?
NCT05916183 is a clinical study titled "Dehydration Cognition". The investigators want to understand the impact of the body losing and gaining water on brain function. Participants will restrict fluids consumed and exercise to lose 5% of body mass. Participants will then be provided fluid equal to the volume lost to consume over 2 hours (recovery). A series of b...
What is the current status of trial NCT05916183?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-07-05. Estimated completion is 2023-12-22.
What conditions does trial NCT05916183 study?
This clinical trial studies the following conditions: Dehydration.
What interventions are being tested in trial NCT05916183?
The interventions under investigation include: Fluid loss and consumption (BEHAVIORAL).
Who is sponsoring clinical trial NCT05916183?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05916183 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dehydration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05916183's enrollment target sits among peer trials
15 19th of 20 higher than 2 of 20 other Dehydration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Efficacy of Education Versus Education Plus Prescribed Fluid Intake on Hydration Status in High School Athletes
RECRUITING · NA
-
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
RECRUITING · NA
-
Adequate Hydration and Health Outcomes
RECRUITING · NA
-
Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults
ACTIVE NOT RECRUITING · NA
-
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI